C
Roche Holding AG RHHVF
$347.00 $8.152.41%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)
C
Hold 8/15/2024Upgraded
Roche Holding AG (RHHVF) was upgraded to C from C- on 8/15/2024 due to an increase in the volatility index, total return index and solvency index. Debt to equity declined from 1.23 to 1.18.
C
Hold 7/17/2024Upgraded
Roche Holding AG (RHHVF) was upgraded to C- from D+ on 7/17/2024 due to an increase in the volatility index and total return index.
D
Sell 5/7/2024Downgrade
Roche Holding AG (RHHVF) was downgraded to D+ from C- on 5/7/2024 due to a decline in the total return index, efficiency index and volatility index. Net income declined 0.25% from $2.47B to $2.46B.
C
Hold 9/6/2023Downgrade
Roche Holding AG (RHHVF) was downgraded to C- from C on 9/6/2023 due to a decline in the growth index, valuation index and volatility index.
C
Hold 7/12/2023Upgraded
Roche Holding AG (RHHVF) was upgraded to C from C- on 7/12/2023 due to an increase in the total return index and valuation index.
C
Hold 2/13/2023Downgrade
Roche Holding AG (RHHVF) was downgraded to C- from C on 2/13/2023 due to a significant decline in the total return index, growth index and volatility index.
C
Hold 7/31/2020Downgrade
Roche Holding AG (RHHVF) was downgraded to C from B on 7/31/2020 due to a noticeable decline in the volatility index, valuation index and growth index.
B
Buy 3/25/2020Upgraded
Roche Holding AG (RHHVF) was upgraded to B from C on 3/25/2020 due to a significant increase in the total return index, volatility index and solvency index. Debt to equity declined from 0.45 to 0.44.
C
Hold 7/30/2018Upgraded
Roche Holding AG (RHHVF) was upgraded to C from C- on 7/30/2018 due to a significant increase in the growth index, valuation index and volatility index.
C
Hold 4/3/2018Downgrade
Roche Holding AG (RHHVF) was downgraded to C- from C on 4/3/2018 due to a decline in the total return index and volatility index.
C
Hold 2/20/2018Upgraded
Roche Holding AG (RHHVF) was upgraded to C from C- on 2/20/2018 due to an increase in the volatility index, valuation index and total return index.
C
Hold 2/2/2018Downgrade
Roche Holding AG (RHHVF) was downgraded to C- from C on 2/2/2018 due to a noticeable decline in the volatility index, total return index and valuation index.
C
Hold 1/10/2017Upgraded
Roche Holding AG (RHHVF) was upgraded to C from C- on 1/10/2017 due to a significant increase in the valuation index.
C
Hold 12/1/2016Downgrade
Roche Holding AG (RHHVF) was downgraded to C- from C on 12/1/2016 due to a decline in the total return index and volatility index.
C
Hold 7/22/2016Upgraded
Roche Holding AG (RHHVF) was upgraded to C from C- on 7/22/2016 due to an increase in the growth index and total return index. Total revenue increased 2.39% from $13.09B to $13.41B, operating cash flow increased 2.39% from $2.85B to $2.92B, and EBIT increased 2.39% from $4.31B to $4.41B.
C
Hold 3/17/2016Downgrade
Roche Holding AG (RHHVF) was downgraded to C- from C on 3/17/2016 due to a significant decline in the volatility index, total return index and growth index. Earnings per share declined from $0.2786 to $0.2715, total revenue declined 2.54% from $13.25B to $12.92B, and operating cash flow declined 2.54% from $4.5B to $4.39B.
C
Hold 6/12/2015Downgrade
Roche Holding AG (RHHVF) was downgraded to C from B on 6/12/2015 due to a significant decline in the valuation index and volatility index.
B
Buy 6/3/2015Upgraded
Roche Holding AG (RHHVF) was upgraded to B from B- on 6/3/2015 due to a large increase in the volatility index and total return index.
B
Buy 5/19/2015Downgrade
Roche Holding AG (RHHVF) was downgraded to B- from B on 5/19/2015 due to a large decline in the volatility index, valuation index and solvency index.
B
Buy 2/6/2015Downgrade
Roche Holding AG (RHHVF) was downgraded to B from B+ on 2/6/2015 due to a substantial decline in the growth index, solvency index and valuation index. Total revenue declined 5.16% from $13.94B to $13.22B, operating cash flow declined 5.16% from $4.56B to $4.32B, and EBIT declined 5.16% from $4.13B to $3.92B.
B
Buy 12/8/2014Upgraded
Roche Holding AG (RHHVF) was upgraded to B+ from C on 12/8/2014 due to a significant increase in the volatility index and total return index.
C
Hold 9/2/2014Upgraded
Roche Holding AG (RHHVF) was upgraded to C from C- on 9/2/2014 due to an increase in the total return index.
C
Hold 8/25/2014None
Roche Holding AG (RHHVF) was downgraded to C- from U on 08/25/2014.
Weiss Ratings